Page last updated: 2024-11-08

desoxycorticosterone acetate and Neuroblastoma

desoxycorticosterone acetate has been researched along with Neuroblastoma in 1 studies

Desoxycorticosterone Acetate: The 21-acetate derivative of desoxycorticosterone.

Neuroblastoma: A common neoplasm of early childhood arising from neural crest cells in the sympathetic nervous system, and characterized by diverse clinical behavior, ranging from spontaneous remission to rapid metastatic progression and death. This tumor is the most common intraabdominal malignancy of childhood, but it may also arise from thorax, neck, or rarely occur in the central nervous system. Histologic features include uniform round cells with hyperchromatic nuclei arranged in nests and separated by fibrovascular septa. Neuroblastomas may be associated with the opsoclonus-myoclonus syndrome. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2099-2101; Curr Opin Oncol 1998 Jan;10(1):43-51)

Research Excerpts

ExcerptRelevanceReference
"We previously reported that binding of prorenin to the (pro)renin receptor (PRR) plays a major role in brain angiotensin II formation and the development of deoxycorticosterone acetate (DOCA)-salt hypertension."3.81Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension. ( Feng, Y; Li, W; Speth, RC; Sullivan, MN; Worker, CJ; Xiong, Z; Zhang, S, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, W1
Sullivan, MN1
Zhang, S1
Worker, CJ1
Xiong, Z1
Speth, RC1
Feng, Y1

Other Studies

1 other study available for desoxycorticosterone acetate and Neuroblastoma

ArticleYear
Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.
    Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Baroreflex; Binding, Competitive; Blood Pressure;

2015